Publicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (10)

2015

  1. MiR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo

    Human Molecular Genetics, Vol. 24, Núm. 23, pp. 6721-6735

  2. Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms

    Scientific Reports, Vol. 5

2013

  1. Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice

    Diabetes, Vol. 62, Núm. 5, pp. 1681-1688

  2. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model

    Aging Cell, Vol. 12, Núm. 1, pp. 11-23

2012

  1. Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S

    Journal of Alzheimer's Disease, Vol. 31, Núm. 4, pp. 741-749

  2. Targeting phospho-Ser422 by active Tau immunotherapy in the THY-Tau22 mouse model: A suitable therapeutic approach

    Current Alzheimer Research, Vol. 9, Núm. 4, pp. 397-405

  3. Tau phosphorylation and sevoflurane anesthesia: An association to postoperative cognitive impairment

    Anesthesiology, Vol. 116, Núm. 4, pp. 779-787

2011

  1. Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of muscleblind-like-1 isoforms

    Journal of Biological Chemistry, Vol. 286, Núm. 18, pp. 16435-16446

  2. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology

    Neurobiology of Disease, Vol. 43, Núm. 2, pp. 486-494

2010

  1. From tau phosphorylation to tau aggregation: What about neuronal death?

    Biochemical Society Transactions, Vol. 38, Núm. 4, pp. 967-972